What is the maximum recommended daily dose of losartan for an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Losartan

The FDA-approved maximum dose of losartan is 100 mg once daily, though clinical trial evidence supports that 150 mg daily provides superior outcomes in heart failure patients. 1

FDA-Approved Maximum Dose

The FDA drug label clearly states that 100 mg once daily is the maximum approved dose for losartan across all indications including hypertension, hypertensive patients with left ventricular hypertrophy, and nephropathy in type 2 diabetic patients 1. Doses above 100 mg daily have not been studied in pediatric patients 1.

The Evidence-Based Discrepancy

There is an important discrepancy between FDA labeling and clinical trial evidence:

Heart Failure Guidelines Support Higher Dosing

  • The 2016 ESC Guidelines recommend a target dose of 150 mg once daily for losartan in heart failure with reduced ejection fraction 2
  • The 2020 ACC/AHA Guidelines acknowledge this discrepancy explicitly, noting: "ACC/AHA Guidelines recommend losartan 150 mg as target dose. However, because current FDA-approved labeling has 100 mg as the maximal dose, the 100-mg dose is used in the performance measure" 3
  • The 2022 AHA/ACC/HFSA Guidelines list the target dose as 50-150 mg once daily, with mean doses achieved in clinical trials of 129 mg total daily 4

The HEAAL Trial Evidence

The Heart failure Endpoint evaluation of Angiotensin II Antagonist Losartan (HEAAL) trial demonstrated that 150 mg daily of losartan was superior to 50 mg daily, showing a 10% relative risk reduction in death or heart failure hospitalization (P = 0.027) over 4.7 years 5, 6, 5, 6. This translates to preventing one primary event for every 31 patients treated for 4 years with 150 mg versus 50 mg 7.

Clinical Application Algorithm

For hypertension or diabetic nephropathy:

  • Maximum dose: 100 mg once daily (FDA-approved limit) 1
  • Starting dose: 50 mg once daily (25 mg if volume depleted) 1

For heart failure with reduced ejection fraction:

  • Target dose per guidelines: 150 mg once daily 2
  • FDA-approved maximum: 100 mg once daily 1
  • Clinical decision: Titrate to 100 mg daily per FDA labeling, recognizing that evidence supports benefit up to 150 mg daily in this population

Dose modifications:

  • Hepatic impairment (mild-to-moderate): Start at 25 mg once daily 1
  • Severe hepatic impairment: Not studied, avoid use 1
  • Renal impairment: No adjustment needed; not removed by hemodialysis 8

Important Caveats

  • The ELITE II trial showed that losartan 50 mg daily was not as effective as captopril 50 mg three times daily, underscoring the importance of adequate dosing 5, 6, 5
  • Dose-response relationships have been demonstrated for renin-angiotensin system blockers, with higher doses providing greater benefit 3
  • In real-world practice, most clinicians adhere to the FDA-approved maximum of 100 mg daily to avoid regulatory and medicolegal concerns, despite guideline recommendations for higher doses in heart failure

References

Research

Losartan: the dose does it.

Expert opinion on pharmacotherapy, 2010

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.